Tolerability and efficacy of anti-androgen manipulation versus taxotere and anti-androgen manipulation in patients with hormone-naive, high-risk/metastatic prostate cancer: A phase II, open-labeled, randomized study.

Trial Profile

Tolerability and efficacy of anti-androgen manipulation versus taxotere and anti-androgen manipulation in patients with hormone-naive, high-risk/metastatic prostate cancer: A phase II, open-labeled, randomized study.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 15 Mar 2011

At a glance

  • Drugs Docetaxel (Primary) ; Goserelin
  • Indications Prostate cancer
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms GENTAX
  • Most Recent Events

    • 15 Mar 2011 New trial record
    • 19 Feb 2011 Interim results presented at the 2011 Genitourinary Cancers Symposium.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top